AzTrials
AzTrials

Reaction of Autonomic Nervous SystemNCT01339715

The Difference Between Acupuncture and Far-infrared Ray Illumination at CV12 Acupoint

A study testing acupuncture and far-infrared ray in people with Reaction of Autonomic Nervous System and Reaction of Acupuncture, run by China Medical University Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study was to investigate the changes of Ryodoraku value at 12 source acupoints, and heart rate viability (HRV) when acupuncture or far-infrared ray illumination applied to CV12 acupoint. Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
What is being tested?
acupuncture and far-infrared ray
Type of treatment
Surgery or procedure
How many people
25 participants
Where
1 siteTaiwan
Study dates
Apr 2011to Mar 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy adult volunteers, male or female, ages between 20 and 40
  • Neurological and physical examination without abnormal functions
  • Far-infrared ray illumination without allergic reaction and contra- indication
  • The participants were explained the objective of the study, agreed to accept the test and signed a letter of consent

Who cannot join

  • People less than 20 years of age or more than 40 years
  • Women in pregnant or lactating
  • People with mental or behavioral anomalies could not follow the researchers
  • People with pacemakers
  • People suffered from serious diseases such as myocardial infarction , heart failure, serious arrhythmia, hypertension, diabetes, autoimmune disease, chronic obstructive pulmonary diseases, and kidney failure, liver cirrhosis and cancer
  • People accepted acupuncture and moxibustion in a week, or were taking any drugs for treatment
Show all 9Show fewer
  • People suffered from limb edema and serious skin diseases
  • People with excessive obesity (body mass index, BMI>30)
  • People did not sign a letter of consent

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • China Medical University Hospital

    Taichung, 404

Other trials in Taiwan

About this study

Official title: From the Changes of Ryodoraku Value at 12 Source Acupoints, and Heart Rate Viability to Explain the Difference Between Acupuncture and Far-infrared Ray Illumination at CV12(Zhongwan)Acupoint

The purpose of the study was to investigate the changes of Ryodoraku value at 12 source acupoints, and heart rate viability (HRV) when acupuncture or far-infrared ray illumination applied to CV12 acupoint.

Read the detailed description

Acupuncture and far-infrared ray illumination at CV12 acupoint have been widely used to treat many diseases in clinic. To our knowledge, the report is about the different reaction on autonomic nervous system between acupuncture and far-infrared illumination is very rare until now.Therefore,the study was to investigate the different changes on autonomic nervous system from Ryodoraku value at 12 source acupoints and heart rate viability (HRV) when acupuncture or far-infrared ray illumination applied to CV12 acupoint.

Being tested
acupuncture and far-infrared ray
Keywords
Ryodoraku, Heart Rate Variability, Traditional medicine, Autonomic Nervous System, Acupuncture, Far Infrared Ray, CV12 Acupoint

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • acupuncture and far-infrared rayProcedure or surgery

    During experimental phase,inserting the needle of acupuncture into CV12 acupoint or using far-infrared ray to illuminate on CV12 20 minutes.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. From the changes of Ryodoraku value at 12 source acupoints, and heart rate viability to measure the difference

    Measured: Each period was 20 min in duration. The Ryodoraku value of 12 source acupoints were measured, and 5-min HRV was recorded at the end of each period.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2011 (estimated)
  2. Study startApr 2011
  3. Primary completionMar 2012
  4. Study completionMar 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01339715
Sponsor's protocol ID
DMR100-IRB-032
Status last verified
Jul 2012
First submitted
17 Apr 2011
Last updated
23 Jul 2012
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing acupuncture and far-infrared ray in people with Reaction of Autonomic Nervous System and Reaction of Acupuncture, run by China Medical University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jul 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

From the changes of Ryodoraku value at 12 source acupoints, and heart rate viability to measure the difference (time frame: Each period was 20 min in duration. The Ryodoraku value of 12 source acupoints were measured, and 5-min HRV was recorded at the end of each period.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in